Talabostat Alleviates Obesity and Associated Metabolic Dysfunction via Suppression of Macrophage‐Driven Adipose Inflammation

Abstract

Our study demonstrates that TB at a low dose could increase energy expenditure and control ATM-mediated adipose inflammation in obese mice, thereby alleviating obesity and its associated metabolic dysfunction.